Increased BTLA expression was observed in mHAg-specific CD8+ T cells compared with memory effector CD8+ T cells in patients with acute myeloid leukemia and multiple myeloma, as well as constitutive expression of HVEM in mHAgs tumor cells. The gene discussed is CD8A; the disease is plasma cell myeloma.